The news is directly about Nuvei. Goldman Sachs, a major financial institution, has maintained a Neutral rating on the company, indicating no major changes in the company's performance. However, the increase in price target from $19 to $21 suggests a positive outlook, which could potentially influence investors' decisions and the stock's performance in the short term.